1 unknown. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Unknown 1 |
Follow BCC - Basal Cell Carcinoma: new trials by email Literature Review of BCC - Basal Cell Carcinoma trials Research Report on BCC - Basal Cell Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Laser Immunotherapy With and Without Topical Anti-PD1 in Basal Cell Carcinomas Nivolumab 10 MG/ML, Ablative fractionated laser - BCC - Basal Cell Carcinoma, Immune Response | Early Phase 1 | Unknown | Bispebjerg Hospital | 30 | 2020-01-27 | 2020-09-30 |
Carcinoma (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Basal Cell (1) · Neoplasms, Glandular and Epithelial (1)
Nivolumab (1)
Denmark (1)